Literature DB >> 9076318

Role of central neural mechanisms in the regulation of hepatic glucose metabolism.

K Nonogaki1, A Iguchi.   

Abstract

Central monoamine neurotransmitters affect blood glucose homeostasis. Activation of central cholinergic, noradrenergic histaminergic, and serotonergic neurons rapidly increase hepatic glucose output via the sympathetic nervous system. Acute hyperglycemia is mediated by three distinct pathways: the action of epinephrine on the liver, the action of glucagon on the liver, and the direct innervation of the liver. The relative contribution of these factors to hyperglycemia can be altered by diet and the kinds of neurotransmitters evoked in the central nervous system, but the magnitude of epinephrine secretion is closely related to the magnitude of hyperglycemia. On the other hand, neuropharmacological stimulation of central cholinergic muscarinic receptors, histaminergic H1 receptors, and serotonergic 5-HT2 receptors increases hypothalamic noradrenergic neuronal activity, which is associated with hyperglycemia. In contrast, central GABAA receptors play an inhibitory role in the regulation of hepatic glucose metabolism. Thus, central monoaminergic neurons could be linked together, and play a homeostatic role in the regulation of hepatic glucose metabolism.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9076318     DOI: 10.1016/s0024-3205(96)00596-6

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  11 in total

1.  Effect of buspirone: An anxiolytic drug on blood glucose in humans.

Authors:  S K Ojha; M Nandave; C Sharma
Journal:  Indian J Clin Biochem       Date:  2006-09

2.  The effects of stimulation and lesioning of afferent nerves on blood glucose and free fatty acid contents in rats in conditions of changing glycemia.

Authors:  V K Spiridonov; N F Vorob'eva
Journal:  Neurosci Behav Physiol       Date:  2000 Mar-Apr

Review 3.  The role of leptin in diabetes: metabolic effects.

Authors:  Thomas H Meek; Gregory J Morton
Journal:  Diabetologia       Date:  2016-03-11       Impact factor: 10.122

Review 4.  Metabolic effects of antihypertensive agents: role of sympathoadrenal and renin-angiotensin systems.

Authors:  Paul Ernsberger; Richard J Koletsky
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2006-06-17       Impact factor: 3.000

5.  Functional identification of a neurocircuit regulating blood glucose.

Authors:  Thomas H Meek; Jarrell T Nelson; Miles E Matsen; Mauricio D Dorfman; Stephan J Guyenet; Vincent Damian; Margaret B Allison; Jarrad M Scarlett; Hong T Nguyen; Joshua P Thaler; David P Olson; Martin G Myers; Michael W Schwartz; Gregory J Morton
Journal:  Proc Natl Acad Sci U S A       Date:  2016-03-21       Impact factor: 11.205

6.  Leptin action in the ventromedial hypothalamic nucleus is sufficient, but not necessary, to normalize diabetic hyperglycemia.

Authors:  Thomas H Meek; Miles E Matsen; Mauricio D Dorfman; Stephan J Guyenet; Vincent Damian; Hong T Nguyen; Gerald J Taborsky; Gregory J Morton
Journal:  Endocrinology       Date:  2013-06-19       Impact factor: 4.736

7.  Do the metabolic effects of beta blockers make them leading or supporting antihypertensive agents in the treatment of hypertension?

Authors:  Panteleimon A Sarafidis; George L Bakris
Journal:  J Clin Hypertens (Greenwich)       Date:  2006-05       Impact factor: 3.738

Review 8.  Mechanisms of the blunting of the sympatho-adrenal response: a theory.

Authors:  B Parekh
Journal:  Curr Diabetes Rev       Date:  2009-05

9.  Leptin, diabetes, and the brain.

Authors:  Thomas H Meek; Gregory J Morton
Journal:  Indian J Endocrinol Metab       Date:  2012-12

10.  Metabolic and hormonal responses to a single session of kumite (free non-contact fight) and kata (highly ritualized fight) in karate athletes.

Authors:  S Benedini; S Longo; A Caumo; L Luzi; P L Invernizzi
Journal:  Sport Sci Health       Date:  2012-11-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.